EFX
38
2
PG
56
5
A
43
2
WFC
79
4
MLM
57
6
ORCL
65
-2
NKE
36
6
GOOGL
40
-5
NTAP
67
-3
URBN
56
14
APD
59
2
DRI
53
5
ACN
52
3
DVN
21
3
UA
50
-9
PM
62
-2
LNC
39
3
CL
58
2
IBM
58
-2
TGT
22
2
EFX
38
2
PG
56
5
A
43
2
WFC
79
4
MLM
57
6
ORCL
65
-2
NKE
36
6
GOOGL
40
-5
NTAP
67
-3
URBN
56
14
APD
59
2
DRI
53
5
ACN
52
3
DVN
21
3
UA
50
-9
PM
62
-2
LNC
39
3
CL
58
2
IBM
58
-2
TGT
22
2
Financhill
Back

Akari Therapeutics PLC Vs. Cellectis SA Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.30
Seasonality Move:
-10.36%
Buy
57

CLLS
Cellectis SA

Last Price:
1.88
Seasonality Move:
2.08%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.30. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.87. The Score for CLLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CLLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 26.66 Sell
Chaikin Money Flow: 110616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.57) Sell
Bollinger Bands (100): (2.43 - 3.73) Sell

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.31 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.93) Buy
Bollinger Bands (100): (1.89 - 2.25) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.8 Sell
20-day SMA: 2.18 Sell
50-day SMA: 2.57 Sell
200-day SMA: 2.53 Sell
8-day EMA: 1.7 Sell
20-day EMA: 2.05 Sell
50-day EMA: 2.47 Sell
200-day EMA: 2.91 Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.91 Sell
20-day SMA: 1.86 Buy
50-day SMA: 1.98 Sell
200-day SMA: 2.35 Sell
8-day EMA: 1.89 Sell
20-day EMA: 1.89 Sell
50-day EMA: 1.96 Sell
200-day EMA: 2.23 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):